Invention Grant
US07879853B2 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
失效
4,6-二取代嘧啶及其作为蛋白激酶抑制剂的用途
- Patent Title: 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
- Patent Title (中): 4,6-二取代嘧啶及其作为蛋白激酶抑制剂的用途
-
Application No.: US11630352Application Date: 2005-06-28
-
Publication No.: US07879853B2Publication Date: 2011-02-01
- Inventor: Josef Stadlwieser , Thomas Baer , Thomas Maier , Thomas Beckers , Thomas Ciossek , Armin Zuelch , Ulrich Graedler
- Applicant: Josef Stadlwieser , Thomas Baer , Thomas Maier , Thomas Beckers , Thomas Ciossek , Armin Zuelch , Ulrich Graedler
- Applicant Address: DE Berlin
- Assignee: Bayer Schering Pharma AG
- Current Assignee: Bayer Schering Pharma AG
- Current Assignee Address: DE Berlin
- Agency: The Nath Law Group
- Agent Joshua B. Goldberg; Robert M. Joynes
- Priority: EP04103011 20040628; EP05102355 20050323
- International Application: PCT/EP2005/053019 WO 20050628
- International Announcement: WO2006/000589 WO 20060105
- Main IPC: C07D405/04
- IPC: C07D405/04 ; A61K31/506
Abstract:
The invention relates to novel pyrimidine derivatives of Formula (1) which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.
Public/Granted literature
- US20070208034A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors Public/Granted day:2007-09-06
Information query
